MoneyWorks4Me

Granules India submits analyst presentation

23 Oct 2019 Evaluate

Granules India has informed that, with reference to Un-audited financial results for the second quarter and half-year ended September 30, 2019 submitted on 22nd October 2019, the company has now submitted the presentation in this regard to the Analysts/ Investors which is also being uploaded on its website. This is pursuant to Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1761.40
Dr. Reddys Labs. 1192.00
Cipla 1307.00
Lupin 1955.05
Zydus Lifesciences 1119.25
View more..